Current surveillance by WHO and CDC shows no novel pathogen with sustained global human-to-human transmission capable of meeting pandemic criteria through late 2027, supporting the 75.5% market-implied odds on "No." The ongoing Bundibugyo Ebola outbreak in DRC and Uganda has been designated a public health emergency of international concern but explicitly does not qualify as a pandemic emergency, with modeling indicating primarily regional impact and low importation risk elsewhere. Post-COVID enhancements in genomic sequencing, contact tracing, and early detection have identified localized threats such as Nipah, H5N1 avian influenza, and hantavirus without escalation, consistent with historical patterns where true pandemics remain infrequent events requiring specific transmissibility and immune-evasion traits absent in present conditions. Trader consensus reflects this baseline risk profile amid stable epidemiological indicators.